
News|Articles|June 1, 2007
FDA pipeline preview, June 2007
The latest FDA action (through June 2007) related to sipuleucel-T (Provenge), tramadol (CIP-Tramadol ER), isotretinoin (CIP-Isotretinoin), bazedoxifene (Viviant), irbesartan plus hydrochlorothiazide (Avalide), prednisolone 1.0% plus tobramycin 0.3% ophthalmic suspension (T-Pred), pixantrone, SPRC-AB01
Advertisement
Approvable designations
Recommendation for approval
Nonapprovable designation
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Sponsored: The Teva Biosimilars Trend Report
2
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
3
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
4
The 6-Year Cure Threshold: Redefining Cure for Colon Cancer Survivors
5